StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Aristotle Blurp from Ichor's Website

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Dec 09, 2020 3:01pm

149 Views

Post# 32069599

RE:Aristotle Blurp from Ichor's Website

Can't wait to see what Ichor and SZLS have planned next. Thanks skrit

Skrit37 wrote:
Cancer Screening Tests

Ichor Blood Services is proud to be working with StageZero Life Sciences to provide mobile lab collection services for their advanced cancer screening tests for those located in Calgary, Edmonton, or Toronto. For the time being we are focusing our efforts on Covid-19 testing, but are anxiously awaiting launch of their Aristotle platform in early 2021. For more information on Stage Zero cancer tests, please visit their website.